ISI Web of Knowledge Take the next step  
Web of Science®
 
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
STUDIES OF V-BETA-8 T-CELL RECEPTOR PEPTIDE TREATMENT IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS
Author(s): STEVENS DB, KARPUS WJ, GOULD KE, SWANBORG RH
Source: JOURNAL OF NEUROIMMUNOLOGY    Volume: 37    Issue: 1-2    Pages: 123-129    Published: MAR 1992  
Times Cited: 41     References: 17     
Abstract: Lewis rats immunized with T cell receptor (TCR) variable region peptide V-beta-8 in complete Freund's adjuvant (CFA) were protected against experimental autoimmune encephalomyelitis (EAE) induced with myelin basic protein in CFA, although variable protection was also observed in rats injected with control peptide in CFA, or CFA alone. However, this adjuvant-mediated protection could be avoided by immunizing with TCR peptide in incomplete adjuvant (IFA). Clinical, but not histologic EAE was suppressed in rats given V-beta-8 peptide in IFA, whereas control animals injected with V-beta-14 peptide in IFA, or IFA alone developed severe clinical EAE. Anti-V-beta-8 antibodies were present in the sera of all V-beta-8-treated rats. These findings lend support to the hypothesis that autoimmune disease can be suppressed by inducing an immune response against the TCR-idiotope of autoreactive T cells.
Document Type: Article
Language: English
Addresses:
1. WAYNE STATE UNIV, SCH MED, DEPT IMMUNOL & MICROBIOL, 540 E CANFIELD AVE, DETROIT, MI 48201 USA
Publisher: ELSEVIER SCIENCE BV, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
Subject Category: Immunology; Neurosciences
IDS Number: HG729
ISSN: 0165-5728
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
  
Thomson Reuters Logo